Abstract: (–)-Canataxpropellane is a complex taxane diterpenoid characterized by a highly oxygenated propellane-type framework. This paper details its first total synthesis, achieved through a strategic sequence featuring an intramolecular [2+2] photocycloaddition, a singlet oxygen cycloaddition, and a pinacol coupling. Key words: (–)-canataxpropellane, taxane diterpenoid, [2+2] cycloaddition, pinacol coupling, 1O2 cycloaddition.
Introduction
The taxane family of natural products includes some of the most structurally demanding targets in organic chemistry, most notably the anticancer drug Taxol (paclitaxel). (–)-Canataxpropellane, isolated from the Canadian yew (Taxus canadensis), represents a particularly challenging member of this family due to its dense, cage-like architecture. It features a unique, highly oxygenated propellane-type framework with multiple fused rings and a high concentration of stereocenters. Prior to this work, the complexity of its core had prevented a complete laboratory synthesis, limiting the ability of researchers to study its biological properties or develop derivatives.
Synthetic Strategy
The synthesis, led by Tanja Gaich at the University of Konstanz, employs several powerful synthetic transformations to build the molecule's intricate skeleton from relatively simple precursors.
The route begins with a Diels–Alder cycloaddition to combine fragments A and B into intermediate C, establishing the initial ring system. The pivotal step of the synthesis is an intramolecular [2+2] photocycloaddition. By irradiating intermediate D with light ($h\nu$), the team successfully snapped the molecule into a strained, fully substituted cyclobutane (E). This single step rapidly generates immense structural complexity, creating the core of the propellane structure and four contiguous stereocenters. To control the absolute stereochemistry, a (–)-TADDOL derivative was utilized as a chiral auxiliary.
Late-stage functionalization was required to manage the high degree of oxygenation. A singlet oxygen ($^1O_2$) cycloaddition was performed on intermediate F, followed by reductive cleavage to introduce necessary oxygen atoms. A Stille carbonylative cross-coupling was then used to link fragments and introduce a carbonyl group, transitioning from I to K. The final ring of the carbon skeleton was closed using a pinacol coupling—a reductive coupling of two carbonyl groups in intermediate L to form a crucial C–C bond, yielding M.
Key Insights and Results
This synthesis highlights the power of photochemistry in total synthesis. The use of light to drive the [2+2] reaction allows for the formation of highly strained bonds that would be difficult, if not impossible, to access via traditional thermal chemistry. Furthermore, the strategy of building the carbon skeleton first and then using reactions like the $^1O_2$ cycloaddition allowed the team to manage the high degree of oxygenation without the intermediates becoming too unstable.
Key results of the study include:
- First Total Synthesis: The authors successfully produced (–)-canataxpropellane from scratch.
- Efficiency in Complexity: Despite the molecule's extreme complexity, several key steps showed impressive yields. The singlet oxygen cycloaddition achieved a 58% yield, and a 4-step sequence to reach intermediate L yielded 73%.
- Pivotal [2+2] Yield: The [2+2] cycloaddition yielded 36% of the desired product E, while also allowing for the recovery of 46% of the starting material D, which could be recycled for further use.
Conclusion and Future Directions
While a landmark achievement in organic synthesis, the route to (–)-canataxpropellane remains a multi-step, labor-intensive process. The overall yield, while high for a molecule of this caliber, is not yet suitable for industrial-scale production. Future research will likely focus on streamlining the synthetic route to reduce the total step count and using this framework to create "taxane-like" analogues. Such derivatives could be tested for improved medicinal properties or reduced toxicity compared to existing taxanes, potentially opening new avenues in anticancer research.
Summary updated